Delivery Order SPE2DB22D1202-SPE2DB24FVNU3
Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $8.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the U.S. Department of Defense's Medical Supply Chain agency. The $1,607.18 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 23, 2024, with a completion date of July 24, 2024. This order is a part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop...
- This federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,511.04 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024 with a completion date of October 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The federal contract award is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,369.35, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a term running through January 23, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $7,935.92 and a completion date of September 25, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This appears to be a delivery order under a larger Indefinite Delivery Contract...
- This federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,625.30 and is a firm fixed-price delivery order with a completion date of November 5, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies....
- This federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,219.14 and a completion date of July 18, 2025. The contract is a firm fixed-price delivery order, awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside and was competitively awarded....
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The contract, valued at $1,553.03, was awarded by the Defense Logistics Agency (DLA) on December 6, 2024, with a completion date of December 9, 2024. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a...
- This federal contract award is for the delivery of XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. The contract, valued at $2,379.57, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with a performance period ending on July 14, 2025. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,450.57 firm-fixed-price delivery order is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of May 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This federal contract award is for the delivery of XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,344.65, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...